Morrison ACTION
2014
CBT for Patients Refusing Antipsychotics
In 74 patients with schizophrenia who declined antipsychotics, CBT alone reduced PANSS total compared with treatment as usual.
Result
Primary endpoint: PANSS total at 18 months
PANSS difference −6.52 (ES −0.46); safe adverse-event profile.
- Subtopic
- Antipsychotic refusers
- Design
- Single-blind RCT, UK
- Relevance
- Supporting: context rather than must-know.
- Source
- Morrison AP, et al. Lancet. 2014;383(9926):1395-1403.doi 10.1016/S0140-6736(13)62246-1
Discussion & critique
Made an evidence-based case for offering CBT as monotherapy when patients refuse antipsychotics.